These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1490144)

  • 1. Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study.
    Sundmacher R; Reinhard T; Heering P
    Ger J Ophthalmol; 1992; 1(6):432-6. PubMed ID: 1490144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perforating keratoplasty in endogenous eczema. An indication for systemic cyclosporin A--a retrospective study of 18 patients].
    Reinhard T; Sundmacher R
    Klin Monbl Augenheilkd; 1992 Sep; 201(3):159-63. PubMed ID: 1405394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute and chronic immune reactions after penetrating keratoplasty with normal immune risk].
    Reinhard T; Hutmacher M; Sundmacher R
    Klin Monbl Augenheilkd; 1997 Mar; 210(3):139-43. PubMed ID: 9206744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases].
    Robert PY; Delbosc B; Preux PM; Monnot PH; Drouet M; Peyronnet P; Adenis JP
    J Fr Ophtalmol; 1997; 20(7):507-14. PubMed ID: 9499974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year postoperative results of penetrating keratoplasty.
    Ing JJ; Ing HH; Nelson LR; Hodge DO; Bourne WM
    Ophthalmology; 1998 Oct; 105(10):1855-65. PubMed ID: 9787355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic cyclosporin A therapy in high risk keratoplasty].
    Bialasiewicz AA; Naumann GO
    Fortschr Ophthalmol; 1989; 86(6):574-80. PubMed ID: 2625283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study.
    Tan DT; Janardhanan P; Zhou H; Chan YH; Htoon HM; Ang LP; Lim LS
    Ophthalmology; 2008 Jun; 115(6):975-982.e1. PubMed ID: 18061267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.
    Patel SV; Hodge DO; Bourne WM
    Am J Ophthalmol; 2005 Feb; 139(2):311-9. PubMed ID: 15733993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty].
    Nguyen NX; Seitz B; Langenbucher A; Wenkel H; Cursiefen C
    Klin Monbl Augenheilkd; 2004 Jun; 221(6):467-72. PubMed ID: 15236106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term graft survival after penetrating keratoplasty.
    Thompson RW; Price MO; Bowers PJ; Price FW
    Ophthalmology; 2003 Jul; 110(7):1396-402. PubMed ID: 12867398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial endothelial cell density and chronic endothelial cell loss rate in corneal transplants with late endothelial failure.
    Nishimura JK; Hodge DO; Bourne WM
    Ophthalmology; 1999 Oct; 106(10):1962-5. PubMed ID: 10519593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on the endothelial immune rejection after penetrating keratoplasty].
    Shi WY; Wang X; Xie LX
    Zhonghua Yan Ke Za Zhi; 2005 Feb; 41(2):145-9. PubMed ID: 15840342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results.
    Spelsberg H; Reinhard T; Henke L; Berschick P; Sundmacher R
    Ophthalmology; 2004 Aug; 111(8):1528-33. PubMed ID: 15288983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["Early" immunologic transplant reactions following perforating keratoplasty. A prospective clinical study].
    Schönherr U; Küchle M; Händel A; Lang GK; Kuntze H; Naumann GO
    Fortschr Ophthalmol; 1990; 87(2):121-3. PubMed ID: 2358265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of corneal graft survival in infants and children with peters anomaly.
    Yang LL; Lambert SR; Lynn MJ; Stulting RD
    Ophthalmology; 1999 Apr; 106(4):833-48. PubMed ID: 10201611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visual acuity and astigmatism after eccentric penetrating keratoplasty - a retrospective study on 117 patients].
    Riedel T; Seitz B; Langenbucher A; Naumann GO
    Klin Monbl Augenheilkd; 2002; 219(1-2):40-5. PubMed ID: 11932809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Australian Corneal Graft Registry. 1990 to 1992 report.
    Aust N Z J Ophthalmol; 1993 May; 21(2 Suppl):1-48. PubMed ID: 8333942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal transplant survival after onset of severe endothelial rejection.
    Wagoner MD; Ba-Abbad R; Sutphin JE; Zimmerman MB
    Ophthalmology; 2007 Sep; 114(9):1630-6. PubMed ID: 17367863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.